Dr. Reddy’s (NYSE: RDY) schedules FY26 results release and earnings call on May 12, 2026
Rhea-AI Filing Summary
Dr. Reddy’s Laboratories filed a Form 6-K to notify investors that it will release its Q4 and full-year FY26 results for the period ended March 31, 2026 on Tuesday, May 12, 2026, after a Board meeting.
The company will distribute the financial results through stock exchanges, media, its website, and email, and will host an earnings call on May 12, 2026 at 19:30 IST / 10:00 ET. An audio recording and transcript of the call, as well as a press meet presentation, will be made available on its website.
Positive
- None.
Negative
- None.
Key Terms
foreign private issuer regulatory
financial results financial
earnings call financial
transcript of the Earnings call financial
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
April, 2026
Commission File Number 1-15182
DR. REDDY’S LABORATORIES LIMITED
(Translation of registrant’s name into English)
8-2-337, Road No. 3, Banjara Hills
Hyderabad, Telangana 500 034, India
+91-40-49002900
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ¨ No x
If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.
EXHIBITS
Exhibit |
| Description of Exhibits |
|
|
|
99.1 | Intimation dated April 24, 2026 |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| DR. REDDY’S LABORATORIES LIMITED (Registrant) | ||
|
| ||
Date: April 24, 2026 | By: | /s/ K Randhir Singh | |
|
| Name: | K Randhir Singh |
|
| Title: | Company Secretary |
| 3 |
Exhibit 99.1
| Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India
CIN: L85195TG1984PLC004507
Tel: + 91 40 4900 2900 Fax: + 91 40 4900 2999 Email: mail@drreddys.com Web: www.drreddys.com
|
April 24, 2026
National Stock Exchange of India Ltd. (Stock Code: DRREDDY-EQ)
BSE Limited (Stock Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Dear Sir/ Madam,
Sub: Intimation of Earnings call
Please find enclosed a notification titled “Dr. Reddy's to release Q4 and full year FY26 results on Tuesday, May 12th, 2026; Earnings call slated @19:30 PM IST / 10:00 AM ET”
This is for your information and records.
Thanking you.
Yours faithfully,
For Dr. Reddy’s Laboratories Limited
K Randhir Singh
Company Secretary, Compliance Officer & Head-CSR
DR. REDDY'S LABORATORIES LTD. 8-2-337, Road No. 3, Banjara Hills, Hyderabad – 500034, Telangana, India. | CONTACT | |
Investor relationS | Media relationS | |
Aishwarya sitharam aishwaryasitharam@drreddys.com | PRIYA K priyak@drreddys.com | |
Dr. Reddy's to release Q4 and full year FY26 results on Tuesday, May 12th, 2026;
Earnings call slated @19:30 PM IST / 10:00 AM ET
Hyderabad, India, April 24th, 2026
Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) will announce results for the quarter and year ended March 31st, 2026 on Tuesday, May 12th, 2026 after the Board Meeting.
Summary of Events
Event | Date and Time | Medium |
Release of financial results | Tuesday, May 12th, 2026, after the Board Meeting | Stock Exchange, Media, Company Website, Email |
Press Meet Presentation | Will be available on the Company’s Website | Stock Exchange, Company’s Website www.drreddys.com |
Earnings Call | Tuesday, May 12th, 2026 at 19:30 PM IST / 10:00 AM ET | Hosted by the Company (Details below) |
Audio as well as Transcript of the Earnings call | Will be available on the Company’s Website | Stock Exchange, Company’s Website www.drreddys.com |
Earnings Call
Following the release, the management of the Company will host its earnings call to discuss the Company’s financial performance.
Pre-register with the link below:
https://drreddys.zoom.us/webinar/register/WN_DW56_eZ6SAGF8FWL6wa-EQ